3.3206
Precigen Inc stock is traded at $3.3206, with a volume of 1.09M.
It is down -0.01% in the last 24 hours and down -24.21% over the past month.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$3.32
Open:
$3.26
24h Volume:
1.09M
Relative Volume:
0.24
Market Cap:
$1.17B
Revenue:
$6.31M
Net Income/Loss:
$-246.87M
P/E Ratio:
-2.3705
EPS:
-1.4008
Net Cash Flow:
$-75.62M
1W Performance:
-5.42%
1M Performance:
-24.21%
6M Performance:
-11.47%
1Y Performance:
+84.43%
Precigen Inc Stock (PGEN) Company Profile
Name
Precigen Inc
Sector
Industry
Phone
301-556-9900
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ALNY, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PGEN
Precigen Inc
|
3.32 | 1.17B | 6.31M | -246.87M | -75.62M | -1.4008 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.83 | 116.36B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
736.25 | 77.96B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.35 | 41.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ARGX
Argen X Se Adr
|
677.78 | 42.36B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ONC
Beone Medicines Ltd Adr
|
281.06 | 31.38B | 5.36B | 287.73M | 924.18M | 2.5229 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-22-24 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Initiated | JP Morgan | Neutral |
| Nov-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-25-21 | Initiated | Stifel | Buy |
| Feb-22-21 | Initiated | Wells Fargo | Overweight |
| Feb-18-21 | Initiated | B. Riley Securities | Buy |
| May-08-20 | Initiated | H.C. Wainwright | Buy |
View All
Precigen Inc Stock (PGEN) Latest News
Precigen, Inc. Hits Day Low of $3.27 Amid Price Pressure - Markets Mojo
Precigen Stock Hits Day Low of $3.94 Amid Price Pressure - Markets Mojo
Precigen (PGEN) insider exercises 143,678 RSUs into common stock - Stock Titan
Director Frank Steven converts 71,839 RSUs into Precigen (PGEN) common stock - Stock Titan
Precigen (PGEN) director converts 71,839 RSUs into common stock, now holding 305,776 shares - Stock Titan
Director at Precigen (PGEN) converts 71,839 vested RSUs into shares - Stock Titan
[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan
Precigen (PGEN) director exercises RSUs, adds 71,839 common shares - Stock Titan
RSU vesting gives Precigen (PGEN) director 71839 new common shares - Stock Titan
RSU vesting adds 71,839 shares to Precigen (PGEN) director’s holdings - Stock Titan
Precigen, Inc. Hits Day High with Strong 7.01% Intraday Surge - Markets Mojo
Boxer Capital Management LLC Makes New $2.80 Million Investment in Precigen, Inc. $PGEN - MarketBeat
Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - MSN
Precigen (NASDAQ:PGEN) Stock Price Up 7.5%Should You Buy? - MarketBeat
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 - The Malaysian Reserve
Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback - simplywall.st
Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates - Yahoo Finance
Randal Kirk (PGEN) reports new Precigen equity awards and large indirect stake - Stock Titan
PRECIGEN (PGEN) director granted RSUs, stock options and shares as compensation - Stock Titan
Precigen (PGEN) director granted RSUs, options and shares as board pay - Stock Titan
Director at Precigen (NASDAQ: PGEN) granted stock, RSUs and options - Stock Titan
PRECIGEN (PGEN) director Vinita Gupta receives RSUs, stock options and shares - Stock Titan
Director at Precigen (NASDAQ: PGEN) receives stock, RSUs and options - Stock Titan
Precigen (PGEN) director awarded stock, RSUs and options as board fees - Stock Titan
Precigen (PGEN) director granted RSUs, stock options and shares as retainer - Stock Titan
Precigen (NASDAQ:PGEN) Upgraded at Zacks Research - MarketBeat
Precigen to Announce Full Year 2025 Financial Results - National Today
Biotech firm Precigen schedules March 25 call on 2025 results - Stock Titan
Precigen (PGEN) to Release Quarterly Earnings on Wednesday - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Gainers Report: Is Precigen Inc forming a bullish divergence2025 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Precigen earnings in focus as gene therapy revenue ramps up By Investing.com - Investing.com Canada
Precigen earnings in focus as gene therapy revenue ramps up - Investing.com
Precigen (PGEN) Surged Following the Early Approval of Papziemos - Insider Monkey
EV Market: Is Precigen Inc stock influenced by commodity prices2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
PGEN Stock Price, Quote & Chart | PRECIGEN INC (NASDAQ:PGEN) - ChartMill
Precigen, Inc. (PGEN) Stock Analysis: Unveiling A 123% Upside Potential In Biotech - DirectorsTalk Interviews
Lansing Street Advisors Takes $1.80 Million Position in Precigen, Inc. $PGEN - MarketBeat
Precigen (NASDAQ:PGEN) Share Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Aug Update: Can Precigen Inc beat the S P 5002025 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Precigen, Inc. Hits Day Low of $4.04 Amid Price Pressure - Markets Mojo
Precigen, Inc. Experiences Evaluation Revision Amidst Mixed Market Performance Indicators - Markets Mojo
Precigen, Inc. (PGEN): Investor Outlook On A Biotech With 88% Potential Upside - DirectorsTalk Interviews
Why analysts remain bullish on Precigen Inc. stockMarket Growth Report & Advanced Technical Analysis Signals - mfd.ru
Key Takeaways - StocksToTrade
Precigen (NASDAQ:PGEN) Shares Down 6%What's Next? - MarketBeat
Strategic Moves Boost PGEN Momentum Amidst Market Shifts - StocksToTrade
Precigen (NASDAQ:PGEN) Hits New 12-Month HighHere's What Happened - MarketBeat
Can Precigen Translate PAPZIMEOS Momentum Into Revenue Growth And Shareholder Gains? - RTTNews
Precigen (NASDAQ:PGEN) Trading 5.2% HigherStill a Buy? - MarketBeat
Precigen stock hits 52-week high at 5.23 USD - Investing.com
Precigen Inc Stock (PGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precigen Inc Stock (PGEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| KIRK RANDAL J | Director |
Dec 22 '25 |
Sale |
4.18 |
1,900,036 |
7,942,150 |
341,189 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):